Clinical Trials

Neoplasms

NCT06372574 2024-09-03

A Study of RO7617991 in Patients With Locally Advanced or Metastatic MAGE-A4-Positive Solid Tumors

Neoplasms, Recurrence

NCT05678283 2024-04-17

A Study of Absorption, Metabolism, and Elimination CC-90010 in Participants With Advanced Solid Tumors

Neoplasms

NCT06362031 2024-04-12

A Study to Explore Treatment Patterns, Treatment Outcomes, Healthcare Resource Utilization in Adult Participants With Acute Myeloid Leukemia (AML) Receiving Venetoclax Through Chart Review

Neoplasms, Leukemia, Myeloid, Acute

NCT05312307 2024-02-26

StrataEXPress

Phase EARLY_PHASE1 Withdrawn

Neoplasms

NCT05104268 2024-02-20

MDOM

Neoplasms, Stomatitis

NCT05454371 2023-11-13

URODETECT-WP2

Genitourinary

Neoplasms, Prostatic Neoplasms

NCT03904069 2023-06-12

Study Evaluating the Safety, Tolerability, and Efficacy of FLT3 CAR-T AMG 553 in FLT3-positive Relapsed/Refractory AML

Neoplasms, Leukemia, Myeloid, Acute

NCT02239575 2023-02-28

GBCPRT0009

Neoplasms

NCT05060276 2023-01-26

Study to Assess an Anti-Trop2 Antibody Drug Conjugate in Relapsed or Refractory Solid Tumors

Neoplasms, Recurrence

NCT05572463 2022-11-18

A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma

Dermatologic

Melanoma, Neoplasms

NCT03884400 2022-11-14

Distribution of Biospecimens From Biorepositories/Biobanks for Research Use

Autoimmune Diseases, Digestive System Diseases, Neoplasms, Nephritis

NCT04985825 2022-09-13

I-PACE

Carcinoma, Neoplasms

NCT04361669 2022-09-07

Hospice Quality Score Assessment Post Pharmacist Intervention

BreastCNSGastrointestinalGynecologic

Cardiovascular Diseases, Dementia, Neoplasms, Nervous System Diseases, Respiration Disorders

NCT02201381 2022-07-18

METRICS

Phase 3 Withdrawn

Brain Neoplasms, Breast Neoplasms, Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Triple Negative Breast Neoplasms

NCT04809012 2022-03-25

Study of STI-3031 in Patients With Selected Relapsed or Refractory Solid Tumors

Phase EARLY_PHASE1 Withdrawn

Neoplasms

NCT04123574 2022-02-24

A Pilot Study of BXCL701 in Patients With Pancreatic Cancer

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT04692389 2022-02-08

Jalosome® Soothing Gel Efficacy Grade 2 or 3 Radiodermatitis.

Neoplasms, Pain, Radiodermatitis

NCT02896049 2021-07-27

Celsius TCS Hyperthermia System PMCF Trial

Hyperthermia, Neoplasms

NCT04464967 2021-05-12

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Recurrence, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT00621413 2021-04-19

Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer

Genitourinary

Neoplasms, Prostatic Neoplasms

NCT03214835 2020-07-20

CDx Biopsies for Detection of Laryngopharyngeal Reflux and Laryngeal Lesions

GastrointestinalHead & Neck

Gastroesophageal Reflux, Laryngeal Diseases, Neoplasms, Laryngopharyngeal Reflux

NCT00753740 2020-06-12

Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.

Gynecologic

Neoplasms, Ovarian Neoplasms

NCT03697824 2019-10-29

Clinical Trial of Safety, Tolerability and Antitumor Activity of Genetically Engineered T Cells in Combination With Anti-Cancer Agents in Relapsed and Refractory Synovial Sarcoma Expressing New York Esophageal Antigen-1 (NY-ESO-1) and/or LAGE-1a

Sarcoma

Neoplasms, Sarcoma, Synovial

NCT02709993 2019-10-14

Consolidation Therapy in Patients With Hematologic Malignancies

Neoplasms, Hematologic Neoplasms

NCT02893748 2019-09-23

HyGIeaCare Prep vs Split-dose PEG Prep Prior to Colonoscopy

Neoplasms, Polyps

NCT02582827 2019-08-28

QUILT-3.014: A Trial of ABI-011 Administered Weekly in Patients With Advanced Solid Tumors or Lymphomas

Lymphoid

Lymphoma, Neoplasms

NCT03785184 2019-08-28

A Study of Venetoclax Plus Lenalidomide and Dexamethasone for the Treatment of Newly Diagnosed t(11;14)-Positive Multiple Myeloma in Subjects Who Are Ineligible for High-Dose Therapy

Plasma cell

Multiple Myeloma, Neoplasms

NCT02657447 2019-01-10

Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02)

LymphoidOther hematologic neoplasm

AIDS-Related Complex, Immune System Diseases, Lymphatic Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT03334487 2018-12-26

Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer

Phase 3 Withdrawn

Thoracic

Neoplasms, Small Cell Lung Carcinoma

NCT02939846 2018-09-14

Pharmacokinetics of Single and Repeat Oral Doses of Trametinib in Chinese Subjects With Solid Tumours

Neoplasms

NCT00352950 2018-09-06

Safety Evaluation of Panitumumab and Sirolimus in Advanced Non-Small Cell Lung Cancer

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT02223312 2018-08-28

Therapy for Progressive and/or Refractory Hematologic Malignancies

Neoplasms, Hematologic Neoplasms

NCT02705703 2018-08-28

Consolidation Therapy in Patients With Metastatic Solid Malignancies

Neoplasms

NCT02914327 2018-07-30

Safety and Activity of SNX-5422 Plus Ibrutinib in CLL

LymphoidOther hematologic neoplasm

Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

NCT03077477 2018-06-14

Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers

Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT02155634 2018-04-10

Continuous Lenalidomide Therapy Versus Observation Following Induction Without Lenalidomide, Pomalidomide or Thalidomide in Myeloma

Phase 3 Withdrawn

Plasma cell

Blood Protein Disorders, Hematologic Diseases, Multiple Myeloma, Neoplasms, Paraproteinemias

NCT01328106 2017-12-12

Efficacy and Safety Study of GSK1120212, a MEK Inhibitor, in Subjects With Uveal Melanoma

Dermatologic

Uveal Melanoma, Neoplasms

NCT00408967 2017-08-18

Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression.

Gynecologic

Neoplasms, Ovarian Neoplasms, Recurrence

NCT00386516 2017-08-01

Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer

Gastrointestinal

Bile Duct Neoplasms, Carcinoma, Gallbladder Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence, Cholangiocarcinoma

NCT02674555 2017-07-28

A Study to Investigate the Absorption, Metabolism and Excretion of [14C]ASP8273 in Subjects With Solid Tumors

Neoplasms

NCT03042013 2017-07-11

A Study for Subjects Who Are Participating in an Astellas-sponsored ASP8273 Study

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT02723838 2017-03-07

Study of Intratumoral REOLYSIN® in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy in Muscle-invasive Transitional Cell Carcinoma of the Bladder